Shingles vaccine cuts dementia risk, study finds
Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia


What happened
Getting vaccinated against shingles appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia, according to a study published Wednesday in the journal Nature. The study, based on the health records of 280,000 people in Wales, found that those who received an older live-virus vaccine, Zostavax, were 20% less likely to develop dementia within seven years than those not vaccinated.
Who said what
Previous research suggested that "shingles vaccinations might reduce dementia risk," including a 2024 study that found even greater protection from the newer vaccine Shingrix, The New York Times said. But the latest study overcame limitations in earlier observational data by taking advantage of a "natural experiment" in Wales, where health officials allowed 79-year-olds to get vaccinated but not 80-year-olds, effectively creating a randomized trial among two groups born weeks apart.
A 20% dementia reduction from the shingles vaccine would be "quite important," especially as "we don’t really have much else at the moment that slows down the onset of dementia," Oxford researcher Dr. Paul Harrison, who wasn't involved in this study, told the Times. People should get vaccinated regardless, Dr. Aarati Didwania of Northwestern University said to NBC News. "Shingles is a terrible, painful and debilitating condition that can lead to horrendous long-term pain."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Further research is needed to understand why viruses like shingles and other members of the herpes family appear to boost dementia odds, why the shingles vaccine offers protection and the efficacy of Shingrix.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
5 thin-skinned cartoons about shooting the messenger
Cartoons Artists take on unfavorable weather, a look in the mirror, and more
-
Is Trump's new peacemaking model working in DR Congo?
Talking Point Truce brokered by the US president in June is holding, but foundations of a long-term peace have let to be laid
-
Crossword: August 10, 2025
The Week's daily crossword puzzle
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Why the FDA wants to restrict kratom-related products
In the Spotlight The compound is currently sold across the United States
-
Food may contribute more to obesity than exercise
Under the radar The devil's in the diet
-
Not just a number: how aging rates vary by country
The explainer Inequality is a key factor
-
Scientists have identified 4 distinct autism subtypes
Under the radar They could lead to more accurate diagnosis and care
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system